Your browser is no longer supported. Please, upgrade your browser.
VIR [NASD]
Vir Biotechnology, Inc.
Index- P/E- EPS (ttm)-3.10 Insider Own5.40% Shs Outstand127.74M Perf Week-5.69%
Market Cap5.80B Forward P/E- EPS next Y-1.08 Insider Trans-2.42% Shs Float113.07M Perf Month3.62%
Income-390.30M PEG- EPS next Q-0.48 Inst Own79.20% Short Float7.62% Perf Quarter-17.47%
Sales72.60M P/S79.89 EPS this Y56.50% Inst Trans-4.79% Short Ratio12.05 Perf Half Y36.13%
Book/sh5.10 P/B8.58 EPS next Y70.20% ROA-42.50% Target Price- Perf Year22.76%
Cash/sh5.53 P/C7.91 EPS next 5Y7.00% ROE-56.90% 52W Range25.31 - 141.01 Perf YTD63.33%
Dividend- P/FCF- EPS past 5Y- ROI-41.40% 52W High-68.06% Beta-
Dividend %- Quick Ratio2.80 Sales past 5Y- Gross Margin- 52W Low77.93% ATR2.70
Employees340 Current Ratio2.80 Sales Q/Q-64.90% Oper. Margin- RSI (14)50.06 Volatility4.75% 5.99%
OptionableYes Debt/Eq0.00 EPS Q/Q-85.50% Profit Margin- Rel Volume0.56 Prev Close43.74
ShortableYes LT Debt/Eq0.00 EarningsMay 06 AMC Payout- Avg Volume714.97K Price45.03
Recom2.10 SMA200.51% SMA50-0.01% SMA2006.25% Volume186,747 Change2.96%
Jun-04-21Resumed Robert W. Baird Neutral $45
Jan-27-21Downgrade JP Morgan Neutral → Underweight $30
Jan-20-21Reiterated H.C. Wainwright Buy $100 → $125
Oct-05-20Initiated BofA Securities Buy $55
Sep-14-20Upgrade Goldman Neutral → Buy $48 → $54
Sep-11-20Upgrade JP Morgan Underweight → Neutral $29
Aug-20-20Initiated Needham Buy $62
Mar-19-20Downgrade JP Morgan Neutral → Underweight $26
Mar-13-20Downgrade Goldman Buy → Neutral
Feb-27-20Downgrade Robert W. Baird Neutral → Underperform $17
Feb-04-20Downgrade JP Morgan Overweight → Neutral $25 → $26
Nov-14-19Initiated Robert W. Baird Neutral
Nov-05-19Initiated JP Morgan Overweight $25
Nov-05-19Initiated Goldman Buy $37
Nov-05-19Initiated Cowen Outperform
Nov-05-19Initiated Barclays Overweight $25
Jun-14-21 08:00AM  
Jun-02-21 04:05PM  
May-28-21 05:21PM  
10:44AM  
May-27-21 08:10AM  
07:44AM  
06:29AM  
May-26-21 06:57PM  
05:55PM  
May-24-21 12:27PM  
May-21-21 11:56AM  
09:26AM  
08:04AM  
02:19AM  
May-19-21 06:44AM  
May-10-21 04:05PM  
May-07-21 05:53AM  
May-06-21 07:35PM  
04:05PM  
Apr-29-21 05:04PM  
Apr-22-21 04:01PM  
Apr-21-21 08:50AM  
08:00AM  
08:00AM  
06:52AM  
Apr-17-21 06:00AM  
Apr-16-21 07:14AM  
Apr-15-21 09:51AM  
08:59AM  
Apr-08-21 08:30AM  
Apr-06-21 04:01PM  
Apr-05-21 09:08AM  
08:00AM  
Mar-31-21 01:33PM  
Mar-29-21 08:44AM  
08:30AM  
08:30AM  
Mar-26-21 12:42PM  
08:40AM  
08:30AM  
Mar-25-21 10:55PM  
Mar-24-21 01:03AM  
Mar-21-21 10:29PM  
Mar-18-21 05:13PM  
Mar-16-21 10:33PM  
02:09PM  
07:35AM  
Mar-14-21 09:21PM  
06:35AM  
Mar-12-21 09:33AM  
08:04AM  
06:20AM  
Mar-11-21 05:12PM  
04:18PM  
08:38AM  
08:19AM  
06:45AM  
05:13AM  
Mar-10-21 08:22PM  
12:05AM  
Mar-07-21 08:55PM  
Mar-05-21 09:04AM  
07:54AM  
Mar-04-21 02:47PM  
12:52PM  
10:27AM  
08:35AM  
08:29AM  
Mar-03-21 04:35PM  
02:57PM  
12:55PM  
09:00AM  
Feb-25-21 04:01PM  
Feb-17-21 02:20PM  
01:00PM  
09:29AM  
08:10AM  
07:10AM  
07:04AM  
Feb-11-21 04:01PM  
Feb-01-21 11:30AM  
10:34AM  
08:00AM  
07:00AM  
Jan-29-21 12:57PM  
12:22PM  
Jan-28-21 10:28AM  
Jan-27-21 01:45PM  
12:40PM  
10:08AM  
07:35AM  
06:45AM  
06:45AM  
05:39AM  
Jan-26-21 05:01PM  
08:00AM  
Jan-20-21 01:43PM  
Jan-13-21 02:11PM  
10:00AM  
Jan-12-21 04:31PM  
Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 for the prevention of influenza A virus; VIR-1111 for the prevention of human immunodeficiency virus; and VIR-2020 for the prevention of tuberculosis. The company has grant agreements with Bill & Melinda Gates Foundation and National Institutes of Health; an option and license agreement with Brii Biosciences Limited and Brii Biosciences Offshore Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; a collaboration, license, and option agreement with Visterra, Inc.; license agreements with The Rockefeller University and MedImmune, Inc.; a collaboration with WuXi Biologics; and a collaborative research agreement with Generation Bio., as well as GlaxoSmithKline Intellectual Property Development Limited, GlaxoSmithKline Biologicals SA., and Alnylam Pharmaceuticals, Inc. It also has a manufacturing agreement with Samsung Biologics Co.,Ltd. for the manufacture of SARS-COV-2 antibodies for potential COVID-19 treatment; and clinical collaboration with Gilead Sciences, Inc. for chronic hepatitis B virus. Vir Biotechnology, Inc. was founded in 2016 and is headquartered in San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MORE ROBERT JDirectorJun 03Sale44.5611,670520,03381,039Jun 07 08:36 PM
Pang PhillipChief Medical OfficerJun 02Option Exercise0.8510,0008,550119,277Jun 03 07:30 PM
Pang PhillipChief Medical OfficerJun 02Sale41.4910,000414,874109,277Jun 03 07:30 PM
Virgin HerbertEVP, Research & CSOJun 01Option Exercise1.531,3752,10493,075Jun 02 05:38 PM
Virgin HerbertEVP, Research & CSOJun 01Sale42.511,37558,45191,700Jun 02 05:38 PM
MORE ROBERT JDirectorMay 20Sale44.5011,670519,35189,335May 24 09:25 PM
SATO VICKI LDirectorMay 19Sale43.8015,174664,6011,653,936May 20 07:53 PM
Virgin HerbertEVP, Research & CSOMay 18Option Exercise1.531,3752,10493,075May 19 04:39 PM
Virgin HerbertEVP, Research & CSOMay 18Sale45.031,37561,91691,700May 19 04:39 PM
Virgin HerbertEVP, Research & CSOMay 04Option Exercise1.531,3752,10493,075May 05 07:36 PM
Virgin HerbertEVP, Research & CSOMay 04Sale46.031,37563,29191,700May 05 07:36 PM
Virgin HerbertEVP, Research & CSOApr 27Option Exercise1.537,90012,08799,600Apr 28 04:41 PM
Virgin HerbertEVP, Research & CSOApr 27Sale49.507,900391,07791,700Apr 28 04:41 PM
Virgin HerbertEVP, Research & CSOApr 19Option Exercise1.532,3403,58094,040Apr 20 06:18 PM
Virgin HerbertEVP, Research & CSOApr 19Sale48.002,340112,32091,700Apr 20 06:18 PM
Virgin HerbertEVP, Research & CSOApr 16Option Exercise1.533,5005,35591,700Apr 19 08:00 PM
Virgin HerbertEVP, Research & CSOApr 13Option Exercise1.535,5608,50793,760Apr 15 05:36 PM
Virgin HerbertEVP, Research & CSOApr 13Sale43.575,560242,24488,200Apr 15 05:36 PM
Virgin HerbertEVP, Research & CSOApr 09Option Exercise1.5314,00021,42088,200Apr 12 08:23 PM
Parrish JayChief Business OfficerApr 01Option Exercise1.526,94410,52016,204Apr 05 05:00 PM
Parrish JayChief Business OfficerApr 01Sale51.406,944356,9569,260Apr 05 05:00 PM
Virgin HerbertEVP, Research & CSOMar 23Option Exercise1.537,90012,08782,100Mar 25 05:26 PM
Virgin HerbertEVP, Research & CSOMar 23Sale53.607,900423,40874,200Mar 25 05:26 PM
Virgin HerbertEVP, Research & CSOMar 10Option Exercise1.532,3403,58076,540Mar 12 04:28 PM
Virgin HerbertEVP, Research & CSOMar 10Sale48.002,340112,32074,200Mar 12 04:28 PM
Virgin HerbertEVP, Research & CSOMar 09Option Exercise1.535,5608,50779,760Mar 10 04:58 PM
Virgin HerbertEVP, Research & CSOMar 09Sale44.805,560249,08674,200Mar 10 04:58 PM
Parrish JayChief Business OfficerMar 01Option Exercise1.516,94410,52016,204Mar 03 04:35 PM
Parrish JayChief Business OfficerMar 01Sale63.446,944440,5319,260Mar 03 04:35 PM
Virgin HerbertEVP, Research & CSOFeb 23Option Exercise1.5318,90028,91782,100Feb 25 04:25 PM
Virgin HerbertEVP, Research & CSOFeb 23Sale63.747,900503,57774,200Feb 25 04:25 PM
Pang PhillipChief Medical OfficerFeb 16Option Exercise0.8510,0008,55077,277Feb 18 05:01 PM
Pang PhillipChief Medical OfficerFeb 12Option Exercise0.8510,0008,55067,277Feb 17 05:25 PM
Virgin HerbertEVP, Research & CSOFeb 09Option Exercise1.537,90012,08741,100Feb 10 04:33 PM
Virgin HerbertEVP, Research & CSOFeb 09Sale71.167,900562,16133,200Feb 10 04:33 PM
Parrish JayChief Business OfficerFeb 01Option Exercise1.556,94410,729229,166Feb 02 06:00 PM
Parrish JayChief Business OfficerFeb 01Sale69.916,944485,424222,222Feb 02 06:00 PM
Virgin HerbertEVP, Research & CSOJan 26Option Exercise1.5331,30047,88964,500Jan 27 06:39 PM
Virgin HerbertEVP, Research & CSOJan 26Sale48.1731,3001,507,80633,200Jan 27 06:39 PM
Virgin HerbertEVP, Research & CSOJan 15Option Exercise1.5310,53016,11143,730Jan 19 05:00 PM
Virgin HerbertEVP, Research & CSOJan 15Sale38.0010,530400,14033,200Jan 19 05:00 PM
Virgin HerbertEVP, Research & CSOJan 12Option Exercise1.533,8055,82237,005Jan 13 06:38 PM
Virgin HerbertEVP, Research & CSOJan 12Sale29.363,805111,69633,200Jan 13 06:38 PM
Parrish JayChief Business OfficerJan 04Option Exercise1.496,94510,313229,167Jan 05 04:40 PM
Parrish JayChief Business OfficerJan 04Sale26.326,945182,795222,222Jan 05 04:40 PM
Virgin HerbertEVP, Research & CSODec 24Option Exercise1.539,50014,53533,200Dec 28 06:39 PM
Virgin HerbertEVP, Research & CSODec 22Option Exercise1.533,8055,82227,505Dec 23 06:06 PM
Virgin HerbertEVP, Research & CSODec 22Sale31.193,805118,68323,700Dec 23 06:06 PM
Virgin HerbertEVP, Research & CSODec 08Option Exercise1.533,8055,82227,505Dec 10 05:00 PM
Virgin HerbertEVP, Research & CSODec 08Sale31.273,805118,96623,700Dec 10 05:00 PM
Parrish JayChief Business OfficerDec 01Option Exercise1.516,94510,522229,167Dec 02 05:48 PM
Parrish JayChief Business OfficerDec 01Sale31.536,945218,968222,222Dec 02 05:48 PM
Virgin HerbertEVP, Research & CSONov 27Option Exercise1.532,9304,48326,630Dec 01 07:02 PM
Pang PhillipChief Medical OfficerNov 27Option Exercise0.857,5006,41257,277Dec 01 07:03 PM
Virgin HerbertEVP, Research & CSONov 27Sale30.002,93087,90023,700Dec 01 07:02 PM
Virgin HerbertEVP, Research & CSONov 24Option Exercise1.532,3403,58026,040Nov 25 05:00 PM
Virgin HerbertEVP, Research & CSONov 24Sale27.292,34063,84823,700Nov 25 05:00 PM
Pang PhillipChief Medical OfficerNov 12Option Exercise0.8520,00017,10049,777Nov 16 05:00 PM
Virgin HerbertEVP, Research & CSONov 10Option Exercise1.532,3403,58026,040Nov 12 05:00 PM
Virgin HerbertEVP, Research & CSONov 10Sale26.262,34061,44823,700Nov 12 05:00 PM
Pang PhillipChief Medical OfficerNov 04Option Exercise1.535,0007,65034,777Nov 05 05:00 PM
Parrish JayChief Business OfficerNov 02Option Exercise1.526,94410,520229,166Nov 03 05:00 PM
Parrish JayChief Business OfficerNov 02Sale31.276,944217,153222,222Nov 03 05:00 PM
Virgin HerbertEVP, Research & CSOOct 27Option Exercise1.533,8055,82227,505Oct 28 07:43 PM
Virgin HerbertEVP, Research & CSOOct 27Sale35.043,805133,33523,700Oct 28 07:43 PM
Pang PhillipChief Medical OfficerOct 21Option Exercise2.2112,50027,66742,277Oct 22 06:15 PM
Pang PhillipChief Medical OfficerOct 21Sale31.445,000157,20929,777Nov 05 05:00 PM
Pang PhillipChief Medical OfficerOct 21Sale35.4912,500443,60829,777Oct 22 06:15 PM
Virgin HerbertEVP, Research & CSOOct 13Option Exercise1.535,5608,50729,260Oct 14 06:33 PM
Virgin HerbertEVP, Research & CSOOct 13Sale43.035,560239,23623,700Oct 14 06:33 PM
Pang PhillipChief Medical OfficerOct 07Option Exercise1.5412,50019,22942,277Oct 08 05:00 PM
Pang PhillipChief Medical OfficerOct 07Sale41.7412,500521,79529,777Oct 08 05:00 PM
Parrish JayChief Business OfficerOct 01Option Exercise1.516,94510,522229,167Oct 02 05:19 PM
Parrish JayChief Business OfficerOct 01Sale34.756,945241,342222,222Oct 02 05:19 PM
Virgin HerbertEVP, Research & CSOSep 29Option Exercise1.533,5105,37027,210Oct 01 05:00 PM
Virgin HerbertEVP, Research & CSOSep 29Sale38.003,510133,38023,700Oct 01 05:00 PM
Virgin HerbertEVP, Research & CSOSep 24Option Exercise1.533,7005,66123,700Sep 28 05:00 PM
Virgin HerbertEVP, Research & CSOSep 22Option Exercise1.533,8055,82223,805Sep 23 05:00 PM
Virgin HerbertEVP, Research & CSOSep 22Sale31.713,805120,63820,000Sep 23 05:00 PM
Pang PhillipChief Medical OfficerSep 16Option Exercise2.2412,50028,00142,277Sep 18 05:00 PM
Pang PhillipChief Medical OfficerSep 16Sale31.9012,500398,69429,777Sep 18 05:00 PM
Virgin HerbertEVP, Research & CSOSep 08Option Exercise1.533,8055,82223,805Sep 10 04:30 PM
Virgin HerbertEVP, Research & CSOSep 08Sale29.993,805114,09820,000Sep 10 04:30 PM
Pang PhillipChief Medical OfficerSep 02Option Exercise1.5712,50019,68842,277Sep 03 04:23 PM
Pang PhillipChief Medical OfficerSep 02Sale32.8912,500411,15929,777Sep 03 04:23 PM
Parrish JayChief Business OfficerSep 01Option Exercise1.576,94310,935229,165Sep 03 04:22 PM
Parrish JayChief Business OfficerSep 01Sale39.156,943271,796222,222Sep 03 04:22 PM
Virgin HerbertEVP, Research & CSOAug 25Option Exercise1.5325,56039,10725,560Sep 10 04:29 PM
Virgin HerbertEVP, Research & CSOAug 25Sale42.925,560238,63220,000Sep 10 04:29 PM
Pang PhillipChief Medical OfficerAug 19Option Exercise1.5126,50039,99242,277Aug 21 04:39 PM
Pang PhillipChief Medical OfficerAug 19Sale50.9512,500636,85529,777Aug 21 04:39 PM
Virgin HerbertEVP, Research & CSOAug 11Option Exercise1.537,90012,0877,900Aug 12 04:30 PM
Virgin HerbertEVP, Research & CSOAug 11Sale51.087,900403,5630Aug 12 04:30 PM
Pang PhillipChief Medical OfficerAug 05Option Exercise1.5712,50019,68828,277Aug 07 05:40 PM
Pang PhillipChief Medical OfficerAug 05Option Exercise1.5712,50019,68828,277Aug 07 05:07 PM
Pang PhillipChief Medical OfficerAug 05Sale50.9012,500636,22215,777Aug 07 05:07 PM
Pang PhillipChief Medical OfficerAug 05Sale50.9012,500636,22215,777Aug 07 05:40 PM
Parrish JayChief Business OfficerAug 03Option Exercise1.5011,11016,665233,332Aug 04 05:14 PM
Parrish JayChief Business OfficerAug 03Sale47.6511,110529,404222,222Aug 04 05:14 PM
Virgin HerbertEVP, Research & CSOJul 28Option Exercise1.537,90012,0877,900Jul 30 07:28 PM